Title for MeetingAbstracts
Alphabetical listing of titles
Anti-CD4 idiotype vaccination in HIV disease: results of a multicenter clinical phase-II-study.
Anti-CD4 idiotype vaccination of HIV+ volunteers.
Anti-CD4 idiotypes: potential for AIDS vaccination.
Anti-CD4 therapy for AIDS suggested by mathematical models.
Anti-CD45 Moab produced after HIV immunization with HIV crude lysate.
Anti-CD7 reagents inhibit HIV-1 induced syncytium formation.
Anti-cellular immunity and protection of SIV vaccinated macaques.
Anti-chemokine antibodies in sera of HIV-1-infected patients.
Anti-cholesterol antibody level changes in HIV positive patients after therapy.
Anti-cholosterol antibody level changes in HIV positive patients after therapy.
Anti-CMV activity of foscarnet in a randomized controlled clinical trial for the treatment of non-sight threatening CMV retinitis.
Anti-CMV human immunoglobulins in the prophylaxis of HCMV disease in HIV positive patients. Preliminary results.
Anti-coagulation for stroke prevention in chronic non-valvular atrial fibrillation.
Anti-D immunoglobulin for treatment of immune thrombocytopenic purpura (ITP): comparison between HIV-related ITP and idiopathic ITP.
Anti-D immunoglobulins (IgG) for long-term treatment of patients with HIV-related or idiopathic immune trombocytopenic purpura (ITP).
Anti-DHBV and -SIV activity of 2',3'-dideoxy-3'-fluoro-guanosine (FLG) in vivo. Eleventh International Conference on Antiviral Research.
Anti-discrimination clauses; addressing HIV/AIDS related discrimination, the case of zambia.
Anti-discrimination law & AIDS-related discrimination: a philosophical analysis.
Anti-discrimination policies in the US increase use of HIV testing.
Anti-discrimination protection through AIDS law.
Anti-EBNA1/anti-EBNA2--ratio in sera of HIV-infected patients.
Anti-Epileptic Medication Regimes: Does Research Translate into Practice?
Anti-Fab autoantibodies crossreact with T-cell receptor and gp160 and cause T-cell dysfunction.
Anti-Fungal Susceptibility Testing: The New NCCLS Standards for Moulds and Yeasts.
Anti-GLQ223 antibodies in treated patients with AIDS and ARC.
Anti-GM2 mediated cytotoxic antibody in HIV-infected adults.
Anti-HBc testing can decrease the risk of transfusion related HIV transmission by more than one third.
ANTI-HBV ACTIVITY OF EMTRICITABINE (FTC) IN PATIENTS CO-INFECTED WITH HIV AND HEPATITIS B VIRUS.
Anti-HBV Activity of Tenofovir Disoproxil Fumarate (TDF) in Lamivudine (LAM) Experienced HIV/HBV Co-Infected.
Anti-HBV Vaccination in HIV-Infection: Sucessful only with CD4 cell count >500/mul combined with a viral load below 1000 cps/ml.